HKU Scholars Hub: Browsing DSpace

Browsing by Author Dowsett, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 4 of 4

	Title	Author(s)	Issue Date
	2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial Journal:The Lancet	Goldhirsch, A Gelber, RD Piccart-Gebhart, MJ de Azambuja, E Procter, M Suter, TM Jackisch, C Cameron, D Weber, HA Heinzmann, D Lago, LD McFadden, E Dowsett, M Untch, M Gianni, L Bell, R Köhne, CH Vindevoghel, A Andersson, M Brunt, AM Otero-Reyes, D Song, S Smith, I Leyland-Jones, B Baselga, J Kwong, A	2013
	Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Journal:The Lancet	Early Breast Cancer Trialists' Collaborative Group, EBCTCG Dowsett, M Forbes, JF Bradley, R Ingle, J Aihara, T Bliss, J Boccardo, F Coates, A Coombes, RC Cuzick, J Dubsky, P Gnant, M Kaufmann, M Kilburn, L Perrone, F Rea, D Thurlimann, B van de Velde, C Pan, H Peto, R Davies, C Gray, R	2015
	Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials Journal:The Lancet	Kwong, DLW Davies, C Godwin, J Gray, R Clarke, M Cutter, D Darby, S McGale, P Pan, HC Taylor, C Wang, YC Dowsett, M Ingle, J Peto, R	2011
	Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer Journal:New England Journal of Medicine	Piccart-Gebhart, MJ Procter, M Leyland-Jones, B Goldhirsch, A Untch, M Smith, I Gianni, L Baselga, J Bell, R Jackisch, C Cameron, D Dowsett, M Barrios, CH Steger, G Huang, CS Andersson, M Inbar, M Lichinitser, M Láng, I Nitz, U Iwata, H Thomssen, C Lohrisch, C Suter, TM Rüschoff, J Sütő, T Greatorex, V Ward, C Straehle, C McFadden, E Dolci, S Gelber, RD Herceptin Adjuvant (HERA) Trial Study Team Kwong, A	2005

Showing results 1 to 4 of 4